U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1 - 10 of 10 results

PIPERACILLIN ANHYDROUS

MORE DETAILS

  9I628532GX

Status:
US Approved Rx (2017)
Source:
ANDA207848
(2017)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207848
First approved in 1981
Source:
PIPRACIL by WYETH PHARMS INC
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050545
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Penicillin-binding protein 2B
10
Penicillin-binding protein 1A
45
Conditions:
Intra-abdominal infections
49
Skin and skin structure infections
80
Female pelvic infections
6
Community-acquired pneumonia
47
Nosocomial pneumonia
10
Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic which exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. Piperacillin sodium salt is used in combination with the β-lactamase inhibitor tazobactam sodium (ZOSYN®) for the treatment of patients with moderate to severe infections caused by susceptible bacteria.

PIPERACILLIN RING OPEN DIMER

MORE DETAILS

P9R57U2568

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

N-PIPERACILLINYL PIPERACILLIN PENICILLOIC ACID

MORE DETAILS

FQ34ULJ5XC

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

PIPERACILLIN PENICILLAMIDE

MORE DETAILS

74A6Y2WJY4

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

L-PIPERACILLIN

MORE DETAILS

WR79XRN93Q

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

PIPERACILLIN METHYL ESTER

MORE DETAILS

XR3XH2Q8TY

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

PIPERACILLIN SULFOXIDE

MORE DETAILS

4AN24MEM3W

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

PIPERACILLIN PENICILLOIC ACID

MORE DETAILS

7NUJ2WS9Z5

Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)

PIPERACILLIN SODIUM

MORE DETAILS

  M98T69Q7HP

Status:
US Approved Rx (2017)
Source:
ANDA207848
(2017)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207848
First approved in 1981
Source:
PIPRACIL by WYETH PHARMS INC
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050545
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Penicillin-binding protein 2B
10
Penicillin-binding protein 1A
45
Conditions:
Intra-abdominal infections
49
Skin and skin structure infections
80
Female pelvic infections
6
Community-acquired pneumonia
47
Nosocomial pneumonia
10
Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic which exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. Piperacillin sodium salt is used in combination with the β-lactamase inhibitor tazobactam sodium (ZOSYN®) for the treatment of patients with moderate to severe infections caused by susceptible bacteria.

PIPERACILLIN

MORE DETAILS

  X00B0D5O0E

Status:
US Approved Rx (2017)
Source:
ANDA207848
(2017)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207848
First approved in 1981
Source:
PIPRACIL by WYETH PHARMS INC
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050545
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Penicillin-binding protein 2B
10
Penicillin-binding protein 1A
45
Conditions:
Intra-abdominal infections
49
Skin and skin structure infections
80
Female pelvic infections
6
Community-acquired pneumonia
47
Nosocomial pneumonia
10
Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic which exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. Piperacillin sodium salt is used in combination with the β-lactamase inhibitor tazobactam sodium (ZOSYN®) for the treatment of patients with moderate to severe infections caused by susceptible bacteria.
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966